Learn more

SHENZHEN BIOCAN TECH CO LTD

Overview
  • Total Patents
    147
  • GoodIP Patent Rank
    9,758
  • Filing trend
    ⇧ 16.0%
About

SHENZHEN BIOCAN TECH CO LTD has a total of 147 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are REGENESIS SCIENCE CO LTD, KOCHANEK STEFAN and BREXOGEN INC.

Patent filings in countries

World map showing SHENZHEN BIOCAN TECH CO LTDs patent filings in countries

Patent filings per year

Chart showing SHENZHEN BIOCAN TECH CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mao Jiyan 147

Latest patents

Publication Filing date Title
WO2020000463A1 Method for preparing jm2 gene knockout mouse
WO2020000472A1 Recombinant vector for promoting overexpression of pink1 protein and construction method thereof
WO2020000439A1 Method for knocking out mouse cd366 gene using crispr/cas9 system
WO2020000453A1 Novel human indo gene-targeted rnai interference fragment, rnai carrier and preparation method therefor and application thereof
WO2020000467A1 Lncrna db327252 over-expression vector and preparation method therefor
WO2020000455A1 Human aprf gene-targeted novel rnai fragment, rnai vector, and preparation method therefor and application thereof
WO2020000438A1 Method for applying crispr/cas9 system in knocking out mice ailim gene
WO2020000469A1 Recombinant vector for promoting overexpression of at2r protein and construction method therefor
WO2020000471A1 Recombinant vector for promoting overexpression of pdss2 protein and construction method therefor
WO2020000462A1 Method for preparing mcdr2 gene knock-out mouse
WO2020000449A1 Modified vector for human pin1 gene editing, preparation method therefor and use thereof
WO2020000460A1 Method for targeted knockout of human lgals9 gene based on crispr/cas9 and specific grna thereof
WO2020000451A1 Novel rnai interference fragment targeting human kat13d gene, rnai vector, and preparation method and application thereof
WO2020000470A1 Recombinant vector for promoting cdc42 protein overexpression and construction method thereof
WO2020000464A1 Method for preparing gl-r gene knock-out mouse
WO2020000450A1 Human cd272 gene-targeting novel rnai fragment, rnai carrier, preparation method for same, and applications thereof
WO2020000457A1 Grna targeting sequence that specifically targets human kat13d gene and use thereof
WO2020000468A1 Lncrna dlx6-as1 overexpression vector and preparation method therefor
WO2020000474A1 Recombinant vector promoting pou5f1 protein overexpression and construction method therefor
WO2020000436A1 Grna targeting sequence for specifically targeting human indo gene and use thereof